Healthcare provider profile · identity verified

Kenneth B. Boyd, M.D.

Internal Medicine · HYANNIS, MA · NPI 1952363707

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Trazodone Hcl	Trazodone Hcl	260	44
Eliquis	Apixaban	247	25
Furosemide	Furosemide	237	29
Atorvastatin Calcium	Atorvastatin Calcium	223	37
Pantoprazole Sodium	Pantoprazole Sodium	177	36
Levothyroxine Sodium	Levothyroxine Sodium	168	23
Gabapentin	Gabapentin	165	28
Quetiapine Fumarate	Quetiapine Fumarate	164	15
Mirtazapine	Mirtazapine	133	20
Lisinopril	Lisinopril	130	22
Spironolactone	Spironolactone	130	16
Metformin Hcl	Metformin Hcl	120	15
Xarelto	Rivaroxaban	119	suppressed
Metoprolol Succinate	Metoprolol Succinate	118	19
Metoprolol Tartrate	Metoprolol Tartrate	114	14
Tamsulosin Hcl	Tamsulosin Hcl	109	17
Sertraline Hcl	Sertraline Hcl	108	15
Potassium Chloride	Potassium Chloride	98	12
Duloxetine Hcl	Duloxetine Hcl	82	suppressed
Amlodipine Besylate	Amlodipine Besylate	80	15
Simvastatin	Simvastatin	74	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	70	suppressed
Donepezil Hcl	Donepezil Hcl	69	suppressed
Olanzapine	Olanzapine	68	suppressed
Levetiracetam	Levetiracetam	66	suppressed
Losartan Potassium	Losartan Potassium	66	suppressed
Meloxicam	Meloxicam	63	12
Clopidogrel	Clopidogrel Bisulfate	61	11
Risperidone	Risperidone	61	suppressed
Jardiance	Empagliflozin	58	suppressed
Aripiprazole	Aripiprazole	57	suppressed
Lamotrigine	Lamotrigine	57	suppressed
Allopurinol	Allopurinol	53	suppressed
Citalopram Hbr	Citalopram Hydrobromide	53	suppressed
Buspirone Hcl	Buspirone Hcl	52	suppressed
Famotidine	Famotidine	49	suppressed
Latanoprost	Latanoprost	49	suppressed
Tramadol Hcl	Tramadol Hcl	47	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	suppressed
Prednisone	Prednisone	45	18
Lorazepam	Lorazepam	44	15
Januvia	Sitagliptin Phosphate	43	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	37	suppressed
Haloperidol	Haloperidol	35	suppressed
Clonazepam	Clonazepam	32	suppressed
Baclofen	Baclofen	31	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	31	suppressed
Lactulose	Lactulose	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	11
Topiramate	Topiramate	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Carvedilol	Carvedilol	29	suppressed
Timolol Maleate	Timolol Maleate	29	suppressed
Doxepin Hcl	Doxepin Hcl	28	suppressed
Insulin Lispro	Insulin Lispro	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Glipizide	Glipizide	27	suppressed
Xifaxan	Rifaximin	27	suppressed
Atenolol	Atenolol	26	suppressed
Benztropine Mesylate	Benztropine Mesylate	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Omeprazole	Omeprazole	26	suppressed
Midodrine Hcl	Midodrine Hcl	25	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	25	suppressed
Carbamazepine	Carbamazepine	24	suppressed
Finasteride	Finasteride	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Betamethasone Valerate	Betamethasone Valerate	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Brilinta	Ticagrelor	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Digoxin	Digoxin	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	20	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Austedo	Deutetrabenazine	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nateglinide	Nateglinide	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error